Literature DB >> 31629762

P-Coumaric acid alleviates experimental diabetic nephropathy through modulation of Toll like receptor-4 in rats.

Omar M Zabad1, Yara A Samra2, Laila A Eissa3.   

Abstract

AIMS: Diabetic nephropathy (DN) is responsible for the occurrence of 30-47% of the incident cases of end-stage renal disease (ESRD) worldwide. DN is a chronic inflammatory disorder, which results from hyperglycemia-induced alterations and leads to renal fibrosis and ESRD. Toll like receptor-4 (TLR-4) participates in regulation of inflammatory response through controlling of innate immune system. P-Coumaric Acid (P-CA) is a natural hydroxycinnamic acid derivative and is widely present in vegetables, fruits, mushrooms and cereals. This study aimed to explore the renoprotective effect of P-CA, as anti-inflammatory and antioxidant natural compound, against experimental DN.
METHODS: DN was induced by single intraperitoneal injection of streptozotocin (45 mg/kg) in rats. In kidney homogenate, levels of TLR-4, interleukin-6 (IL-6) and transforming growth factor β1 (TGFβ1) were measured using ELISA technique. Also, kidney collagen content was determined colorimetrically. KEY
FINDINGS: Oral administration of P-CA (100 mg/kg) for 8 weeks significantly alleviated the DN. P-CA significantly reduced serum concentrations of glucose, creatinine, blood urea nitrogen (BUN) and reduced protein content in urine. Also, P-CA significantly increased superoxide dismutase (SOD) activity and significantly reduced kidney contents of malondialdehyde (MDA), TLR-4, IL-6, TGFβ1 and collagen when compared with DN group. Moreover, P-CA significantly improved DN-induced histopathological abnormalities. SIGNIFICANCE: P-CA confers protection against the progression of DN. This renoprotective effect can be attributed to its ability to decrease the generation of inflammatory and fibrotic cytokines in addition to restoring oxidant/antioxidant balance through its ability to down-regulate TLR-4 activation.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Diabetes; Diabetic nephropathy; Interleukin-6; P-Coumaric acid; TGFβ1; TLR-4; Toll like receptor-4; Transforming growth factor β1

Mesh:

Substances:

Year:  2019        PMID: 31629762     DOI: 10.1016/j.lfs.2019.116965

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  10 in total

Review 1.  Pharmacological Activities of Safflower Yellow and Its Clinical Applications.

Authors:  Yan Chen; Meifeng Li; Jiayu Wen; Xiaoqi Pan; Zixin Deng; Junren Chen; Guanru Chen; Lei Yu; Yunli Tang; Gangmin Li; Xiaofang Xie; Cheng Peng
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-27       Impact factor: 2.650

2.  P-Coumaric Acid Reverses Depression-Like Behavior and Memory Deficit Via Inhibiting AGE-RAGE-Mediated Neuroinflammation.

Authors:  Xu-Dong Yu; Dan Zhang; Chu-Li Xiao; Yu Zhou; Xing Li; Le Wang; Zhiming He; James Reilly; Zhi-Yong Xiao; Xinhua Shu
Journal:  Cells       Date:  2022-05-10       Impact factor: 7.666

Review 3.  A review on the phytochemistry and pharmacology of the herb Scoparia dulcis L. for the potential treatment of metabolic syndrome.

Authors:  Zikang Jiang; Jinghui Sung; Xuyun Wang; Yangyang Zhang; Yaomiao Wang; Haifeng Zhou; Lei Wen
Journal:  RSC Adv       Date:  2021-09-22       Impact factor: 4.036

4.  Extraction of Phenolic Compounds from Tabernaemontana catharinensis Leaves and Their Effect on Oxidative Stress Markers in Diabetic Rats.

Authors:  Rafael Sari; Paula Conterno; Leticia Dangui da Silva; Vanderlei Aparecido de Lima; Tatiane Luiza Cadorin Oldoni; Gustavo Roberto Thomé; Solange Teresinha Carpes
Journal:  Molecules       Date:  2020-05-21       Impact factor: 4.411

5.  Alkyl and Aryl Derivatives Based on p-Coumaric Acid Modification and Inhibitory Action against Leishmania braziliensis and Plasmodium falciparum.

Authors:  Susiany P Lopes; Lina M Yepes; Yunierkis Pérez-Castillo; Sara M Robledo; Damião P de Sousa
Journal:  Molecules       Date:  2020-07-11       Impact factor: 4.411

6.  Rice Bran Phenolic Extracts Modulate Insulin Secretion and Gene Expression Associated with β-Cell Function.

Authors:  Nancy Saji; Nidhish Francis; Lachlan J Schwarz; Christopher L Blanchard; Abishek B Santhakumar
Journal:  Nutrients       Date:  2020-06-24       Impact factor: 5.717

Review 7.  The Use of Bioactive Compounds in Hyperglycemia- and Amyloid Fibrils-Induced Toxicity in Type 2 Diabetes and Alzheimer's Disease.

Authors:  Ancuta-Veronica Lupaescu; Monica Iavorschi; Mihai Covasa
Journal:  Pharmaceutics       Date:  2022-01-20       Impact factor: 6.321

8.  Simultaneous measurement of tadehaginoside and its principal metabolite in rats by HPLC-MS/MS and its application in pharmacokinetics and tissue distribution study.

Authors:  Cai-Yun Zhang; Ya-Ting Lu; Yin-Feng Tan; Qi-Bing Liu; Lin Dong; Ning Ma; Wei-Ying Lu; Zhi-Heng Su; Xiao-Po Zhang
Journal:  Pharm Biol       Date:  2021-12       Impact factor: 3.503

9.  Effects of Shenkang Pills on Early-Stage Diabetic Nephropathy in db/db Mice via Inhibiting AURKB/RacGAP1/RhoA Signaling Pathway.

Authors:  Fujing Wang; Jia'er Fan; Tingting Pei; Zhuo'en He; Jiaxing Zhang; Liliang Ju; Zhongxiao Han; Mingqing Wang; Wei Xiao
Journal:  Front Pharmacol       Date:  2022-02-11       Impact factor: 5.810

10.  Nephroprotective effect of Vanillic acid in STZ-induced diabetic rats.

Authors:  Savita Kumari; Anjoo Kamboj; Manish Wanjari; Anil Kumar Sharma
Journal:  J Diabetes Metab Disord       Date:  2021-04-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.